Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-26-054142
Filing Date
2026-05-01
Accepted
2026-05-01 16:15:16
Documents
2
Period of Report
2026-05-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2613221-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2613221-1_3seq1.xml 3 1745
2 EXHIBIT 24 tm2613221d1_ex24.htm EX-24 7236
  Complete submission text file 0001104659-26-054142.txt   10673
Mailing Address C/O REXAHN PHARMACEUTICALS, INC. 15245 SHADY GROVE ROAD SUITE 455 ROCKVILLE MD 20850
Business Address
Swirsky Douglas J (Reporting) CIK: 0001375884 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40367 | Film No.: 26932724

Mailing Address 20400 CENTURY BLVD SUITE 210 GERMANTOWN MD 20874
Business Address 20400 CENTURY BLVD SUITE 210 GERMANTOWN MD 20874 44 (0) 1865 818808
Barinthus Biotherapeutics plc. (Issuer) CIK: 0001828185 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)